Malaria hospitalisation in East Africa: age, phenotype and transmission intensity.Kamau A Paton RS Akech S Mpimbaza A Khazenzi C Ogero M Mumo E Alegana VA Agweyu A Mturi N Mohammed S Bigogo G Audi A Kapisi J Sserwanga A Namuganga JF Kariuki S Otieno NA Nyawanda BO Olotu A Salim N Athuman T Abdulla S Mohamed AF Mtove G Reyburn H Gupta S Lourenco J Bejon P Snow RW
BMC Med, (2022). 20:28

Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity.Rono J Farnert A Murungi L Ojal J Kamuyu G Guleid F Nyangweso G Wambua J Kitsao B Olotu A Marsh K Osier FH
BMC Med, (2015). 13:114

A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.White MT Bejon P Olotu A Griffin JT Bojang K Lusingu J Salim N Abdulla S Otsyula N Agnandji ST Lell B Asante KP Owusu-Agyei S Mahama E Agbenyega T Ansong D Sacarlal J Aponte JJ Ghani AC
BMC Med, (2014). 12:117

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.Warimwe GM Fletcher HA Olotu A Agnandji ST Hill AV Marsh K Bejon P
BMC Med, (2013). 11:184